InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Atlas Venture Fund XII, L.P.. Insider active across 2 companies, notably Aerovate Therapeutics, Inc.. In total, 5 disclosures have been published. The latest transaction was filed on 1 April 2022 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
0465,582 shares0
Common Stock
SEC:0001209191-22-022540:0·
2,831,520 shares
Common Stock
SEC:0000899243-22-001654·
2,831,520 shares
Common Stock
SEC:0000899243-22-001654:0·
2,568,165 shares
Common Stock
SEC:0001104659-21-089434·
2,568,165 shares
Common Stock
SEC:0001104659-21-089434:0·
5 of 5 declarations
About Atlas Venture Fund XII, L.P.
Atlas Venture Fund XII, L.P. is a director and insider, primarily involved with Aerovate Therapeutics, Inc. and Vigil Neuroscience, Inc.
